Skip to main content
OpenTrials

Clinical trial condition

Carcinoid Syndrome

Explore clinical trials studying Carcinoid Syndrome. Study availability and eligibility vary by location and protocol.

18 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Carcinoid Syndrome trial results

Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

NCT07087054

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Intestine Tumor, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Yale University - New Haven Hospital - Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 51 locations
View Trial Details
Completed

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

NCT05361668

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Intestine Tumor, +19 more
Locations
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Newport Beach, California, United States
  • Crinetics Study Site Stanford, California, United States
View all 35 locations
View Trial Details
Completed

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

NCT00774930

Conditions
Adenocarcinoma, Carcinoid Syndrome, Carcinoid Tumor, +17 more
Locations
  • VA Greater Los Angeles Health Care System Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Cedars Sinai Outpatient Cancer Center West Hollywood, California, United States
View all 54 locations
View Trial Details
Completed

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

NCT01234168

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +7 more
Locations
  • Teaching Hospital Brno Bohunice Brno, Czechia
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • Hospital Pardubice Pardubice, Czechia
  • Teaching Hospital Pilsen, Czechia
View all 57 locations
View Trial Details
Completed

Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

NCT02026063

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +1 more
Locations
  • Lexicon Investigational Site Mobile, Alabama, United States
  • Lexicon Investigational Site Stanford, California, United States
  • Lexicon Investigational Site Iowa City, Iowa, United States
  • Lexicon Investigational Site Lexington, Kentucky, United States
View all 43 locations
View Trial Details

Related conditions